James O'Brien

644 total citations
18 papers, 464 citations indexed

About

James O'Brien is a scholar working on Immunology, Epidemiology and Virology. According to data from OpenAlex, James O'Brien has authored 18 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Epidemiology and 4 papers in Virology. Recurrent topics in James O'Brien's work include Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pneumonia and Respiratory Infections (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). James O'Brien is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pneumonia and Respiratory Infections (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). James O'Brien collaborates with scholars based in United States, United Kingdom and Israel. James O'Brien's co-authors include Edward N. Janoff, Josephine M. Ehret, Gordon Meiklejohn, Jacinta Douglas, Peter J. Thompson, Peter Weiss, Mark R. Wallace, Edward C. Oldfield, Paul J. Carson and Kristin L. Nichol and has published in prestigious journals such as Cancer Research, The Journal of Infectious Diseases and The Journal of Pediatrics.

In The Last Decade

James O'Brien

18 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James O'Brien United States 11 251 141 73 54 52 18 464
Kristin MacDonald United States 9 254 1.0× 74 0.5× 39 0.5× 58 1.1× 10 0.2× 9 372
Jeremy Rahkola United States 10 262 1.0× 127 0.9× 15 0.2× 117 2.2× 23 0.4× 23 494
Theresa Joseph United States 10 85 0.3× 132 0.9× 98 1.3× 59 1.1× 8 0.2× 10 376
J. E. Groover United States 11 679 2.7× 219 1.6× 79 1.1× 70 1.3× 39 0.8× 11 801
S Sehgal India 12 171 0.7× 77 0.5× 18 0.2× 101 1.9× 9 0.2× 67 507
Sonali Sanghavi United States 11 294 1.2× 166 1.2× 27 0.4× 152 2.8× 46 0.9× 20 523
A M Reetha India 12 211 0.8× 184 1.3× 52 0.7× 277 5.1× 9 0.2× 27 471
S. Mayor Hungary 5 255 1.0× 376 2.7× 15 0.2× 63 1.2× 20 0.4× 39 728
G Michelone Italy 8 375 1.5× 395 2.8× 17 0.2× 153 2.8× 11 0.2× 27 734
S Kroon Denmark 12 474 1.9× 26 0.2× 264 3.6× 37 0.7× 21 0.4× 31 692

Countries citing papers authored by James O'Brien

Since Specialization
Citations

This map shows the geographic impact of James O'Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James O'Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James O'Brien more than expected).

Fields of papers citing papers by James O'Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James O'Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James O'Brien. The network helps show where James O'Brien may publish in the future.

Co-authorship network of co-authors of James O'Brien

This figure shows the co-authorship network connecting the top 25 collaborators of James O'Brien. A scholar is included among the top collaborators of James O'Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James O'Brien. James O'Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
O'Brien, James, et al.. (2022). Profiling, Privacy, and Protection: Ethical Guidance When Police Are Present at Bedside. Annals of the American Thoracic Society. 19(6). 890–894. 1 indexed citations
2.
O'Brien, James, Xiufen Liu, Tapan K. Bera, et al.. (2017). Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity. Cancer Immunology Research. 5(8). 685–694. 39 indexed citations
3.
Liu, Xiufen, Tapan K. Bera, Masaki Terabe, et al.. (2017). Abstract 58: Local intratumoral treatment with anti-mesothelin Immunotoxins overcomes resistance to anti-CTLA-4 therapy. Cancer Research. 77(13_Supplement). 58–58. 2 indexed citations
4.
O'Brien, James, et al.. (2016). Asymptomatic Left Ventricular Myxoma in a 12-Year-Old Male. Texas Heart Institute Journal. 43(3). 267–269. 6 indexed citations
5.
Ainslie, G., Charles Feldman, Leon Geffen, et al.. (2011). Guideline for the management of chronic obstructive pulmonary disease--2011 update.. PubMed. 101(1 Pt 2). 63–73. 28 indexed citations
6.
Feldman, Charles, et al.. (2004). Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.. PubMed. 94(7 Pt 2). 559–75. 21 indexed citations
7.
Carson, Paul J., et al.. (2000). Immune Function and Vaccine Responses in Healthy Advanced Elderly Patients. Archives of Internal Medicine. 160(13). 2017–2017. 55 indexed citations
8.
Janoff, Edward N., Sybil Tasker, Mario Stevenson, et al.. (1999). Immune Activation and Virologic Response to Immunization in Recent HIV Type 1 Seroconverters. AIDS Research and Human Retroviruses. 15(9). 837–845. 13 indexed citations
9.
O'Brien, James, Martin E. Doerfler, Timothy J. Harkin, & William N. Rom. (1998). Isoniazid Levels in the Bronchoalveolar Lavage Fluid of Patients with Pulmonary Tuberculosis. Lung. 176(3). 205–211. 5 indexed citations
10.
Janoff, Edward N., Claudine E. Fasching, Josephine C. Ojoo, James O'Brien, & Charles F. Gilks. (1997). Responsiveness of Human Immunodeficiency Virus Type 1‐Infected Kenyan Women with or without Prior Pneumococcal Disease to Pneumococcal Vaccine. The Journal of Infectious Diseases. 175(4). 975–978. 33 indexed citations
11.
Weiss, Peter, Mark R. Wallace, Edward C. Oldfield, James O'Brien, & Edward N. Janoff. (1995). Response of Recent Human Immunodeficiency Virus Seroconverters to the Pneumococcal Polysaccharide Vaccine and Haemophilus influenzae Type b Conjugate Vaccine. The Journal of Infectious Diseases. 171(5). 1217–1222. 55 indexed citations
12.
Arpadi, Stephen M., et al.. (1994). Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. The Journal of Pediatrics. 125(1). 77–79. 29 indexed citations
13.
Janoff, Edward N., James O'Brien, Peter J. Thompson, et al.. (1993). Streptococcus pneumoniae Colonization, Bacteremia, and Immune Response among Persons with Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 167(1). 49–56. 101 indexed citations
14.
O'Brien, James, et al.. (1989). Effector characteristics of the IgG3 murine monoclonal antibody 113F1.. PubMed. 8(3). 227–37. 4 indexed citations
15.
Moldofsky, Philip J., et al.. (1988). Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.. PubMed. 48(9). 2568–73. 49 indexed citations
16.
O'Brien, James & W. P. H. Duffus. (1987). Pasteurella haemolytica cytotoxin: Relative susceptibility of bovine leucocytes. Veterinary Microbiology. 13(4). 321–334. 9 indexed citations
17.
O'Brien, James & W. P. H. Duffus. (1987). Neutralization of Pasteurella haemolytica leucotoxin by bovine immunoglobulins. British Veterinary Journal. 143(5). 439–447. 4 indexed citations
18.
O'Brien, James, et al.. (1964). EVALUATION OF A MANAGEMENT DEVELOPMENT PROGRAM. Personnel Psychology. 17(4). 431–440. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026